26 Aug - 29 Aug 2022

ESC Congress 2022


Cereno will present the abstract “CS014 is a novel HDAC inhibitor regulating platelet activity, fibrinolysis and clot stability for prevention of thrombosis without increased risk of bleeding” at the ESC Congress 2022 hosted by the European Society of Cardiology in Barcelona, Spain, on August 26-29.

It will be presented by Dr. Michael Holinstat, lead of Cereno’s preclinical development programs at University of Michigan and Director of Translational Research at Cereno.